chartexchange

CAPS
Capstone Holding Corp. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:30 PM EST
1.74USD-5.435%(-0.10)19,390
Pre-marketNov 13, 2026 9:29:30 AM EST
1.76USD-4.348%(-0.08)
After-hoursNov 13, 2026 4:40:30 PM EST
1.6938USD-2.655%(-0.0462)
Loading…
Loading…
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Tempe, Arizona, USA
Previous Close
$1.76
Beta
7.23
52-Week High
$3.09 2026-10-19
52-Week Low
$0.08 2026-10-16
SMA 50
$0.98
SMA 200
$0.55
Avg. Vol 10D
39,582
Avg. Vol 30D
484,722
Avg. Vol 90D
3.22M
Relative Vol
0.04
917,898
371,552
24.8200%
684
2,477,641
Nov 17, 2026 (2d)
Sep 10, 2019 · 1-for-1000 (reverse)
CAPS Profile

capstone therapeutics (otcqb: caps) is a clinical stage biotechnology company developing a family of new peptide drugs to serve cardiovascular patients with high cholesterol and triglyceride levels otherwise unaddressable through standard therapy. capstone holds an fda orphan drug designation for its lead molecule, aem-28, for homozygous familial hypercholesterolemia (hofh) and may also target indications in acute coronary syndrome, peripheral artery disease and type 2 diabetes.

CAPS Performance
PeriodPriceDateChangeBeta
1W1.902026-11-06-8.42%5.446
1M0.122026-10-13+1300.97%44.781
3M0.222026-08-13+695.97%28.644
6M0.312026-05-13+455.73%13.649
1Y1.032025-11-13+68.93%7.228
2Y3.782024-12-04-53.97%—
5Y17.252021-11-18-89.91%3.238
CAPS Stock Summary

Capstone Holding Corp. Common Stock (NASDAQ:CAPS) stock price today is $1.74, and today's volume is 19,494. CAPS is down 1.136% today. The 30 day average volume is 484,722. CAPS market cap is $1.60M with 917,898 shares outstanding.